Big Nova has made a $3 million donation to support NMDP’s efforts to help more patients, including those with…
Michela Luciano, PhD
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as a scientific writer in 2022. Outside of work, she enjoys street photography, mountain hikes, running, and spending as much time outdoors as possible.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Michela Luciano, PhD
An intervention designed to improve adherence to hydroxyurea — by providing extra support from community health workers (CHWs) and…
Pociredir, an investigational oral therapy for sickle cell disease (SCD), was well tolerated and showed signs of promising activity…
Higher pain scores at the time of discharge from the emergency department (ED) may predict the likelihood of hospitalization in…
BEAM-101, a one-time, gene-edited cell therapy, continues to show durable therapeutic benefits more than one year after treatment in people…